Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the ...

This targeted therapy option just received approval from ... such as Trastuzumab (brand name Herceptin). However, Vyloy is ...

The research, which comes from several groups including Genentech, makers of the prevailing anti-HER2 treatment, has researchers questioning ... By the late ’90s, a drug called Herceptin that targeted ...

It’s likely you’ve seen terms like “personalized medicine,” “precision medicine,” or “targeted ... if Herceptin might work for you. Profiling can also help if other treatment options ...

HER2 positive ER+/PR+ breast cancer are often treated with HER2 targeted therapy such as trastuzumab (Herceptin) in combination with hormone therapy. These targeted therapy work by attacking the ...

Expanding Access to Targeted Therapy with Biosimilars The high cost of monoclonal antibodies like Herceptin has been a major challenge in oncology treatment. Herceptin biosimilars are providing a ...